Related Experiment Video
Updated: Nov 26, 2025

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
Published on: May 24, 2020
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis
Kochawan Boonyawat1, Pichika Chantrathammachart2, Pawin Numthavaj3
1Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Kochawan.boo@mahidol.ac.th.
Insights
Hospitalized COVID-19 patients have a high incidence of venous thromboembolism (VTE), especially in the ICU. Prophylactic measures are recommended for all hospitalized COVID-19 patients to prevent VTE and arterial thromboembolism (ATE).
Area of Science:
- Medicine
- Public Health
- Epidemiology
Background:
- The COVID-19 pandemic has seen a rise in reported thromboembolism cases.
- Understanding the incidence of venous and arterial thromboembolism in hospitalized COVID-19 patients is crucial.
Purpose of the Study:
- To systematically review and explore the incidence of venous thromboembolism (VTE) and arterial thromboembolism (ATE) in hospitalized COVID-19 patients.
Main Methods:
- A systematic review of Medline, Embase, Scopus, and grey literature was conducted until June 2020.
- Included observational studies reporting on VTE (pulmonary embolism, deep vein thrombosis) or ATE incidence.
- Pooled incidences and 95% confidence intervals (CI) were calculated using a random-effects model.
Main Results:
- A total of 36 studies were analyzed.
- The pooled incidence of VTE in the ICU was 28% (95% CI, 22-34%), significantly higher than in non-ICU settings (10%, 95% CI, 6-14%).
- Deep vein thrombosis incidence was higher with compression ultrasound screening (32%) compared to no screening (6%). Arterial thromboembolism incidence in the ICU was 3% (95% CI, 2-5%).
Conclusions:
- COVID-19 patients in the ICU have a higher VTE incidence than non-ICU patients.
- Studies using compression ultrasound screening showed higher DVT rates.
- VTE prophylaxis is recommended for all hospitalized COVID-19 patients.
Background:
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, the incidence of thromboembolism has been increasingly reported. The aim of this systematic review was to explore the incidence of venous and arterial thromboembolism among COVID-19 patients requiring hospitalization.
Methods:
Medline, Embase, Scopus, and grey literature were searched until June 2020. Observational studies reported on the incidence of venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT) or arterial thromboembolism (ATE) were included. The pool incidences and their 95% confidence intervals (CI) were calculated using the random-effects model.
Results:
A total of 36 studies were included. In the intensive care unit (ICU) setting, the pooled incidence of VTE was 28% (95% CI, 22-34%). Subgroups based on compression ultrasound (CUS) screening revealed a higher incidence of DVT in the CUS screening group than in the no CUS screening group (32% [95% CI, 18-45%] vs. 6% [95% CI, 4-9%]). The pooled incidence of ATE in ICU was 3% (95% CI, 2-5%). In the non-ICU setting, the pooled incidence of VTE was 10% (95% CI, 6-14%,).
Conclusions:
The incidence of VTE in COVID-19 patients was higher in the ICU setting than in the non-ICU setting, and also significantly higher in studies that incorporated the CUS screening protocol. The incidence of ATE in the ICU setting was low. VTE prophylactic measures should be given to all hospitalized patients diagnosed with COVID-19.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pulmonary Embolism III: Nursing Management
Venous Thrombosis I: Introduction
